Literature DB >> 18855926

Punding in patients on dopamine agonists for restless leg syndrome.

Andrew H Evans, James R Stegeman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18855926     DOI: 10.1002/mds.22309

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  5 in total

1.  Increased Risk for New-Onset Psychiatric Adverse Events in Patients With Newly Diagnosed Primary Restless Legs Syndrome Who Initiate Treatment With Dopamine Agonists: A Large-Scale Retrospective Claims Matched-Cohort Analysis.

Authors:  Cheryl Hankin; Daniel Lee; Diego Garcia-Borreguero; Zhaohui Wang
Journal:  J Clin Sleep Med       Date:  2019-09-15       Impact factor: 4.062

Review 2.  Brain Imaging and Impulse Control Disorders in Parkinson's Disease.

Authors:  Andreas-Antonios Roussakis; Nicholas P Lao-Kaim; Paola Piccini
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-08       Impact factor: 5.081

Review 3.  Restless legs syndrome: Over 50 years of European contribution.

Authors:  Samson G Khachatryan; Raffaele Ferri; Stephany Fulda; Diego Garcia-Borreguero; Mauro Manconi; Maria-Lucia Muntean; Ambra Stefani
Journal:  J Sleep Res       Date:  2022-07-09       Impact factor: 5.296

4.  Diagnosis and treatment of impulse control disorders in patients with movement disorders.

Authors:  Tiago A Mestre; Antonio P Strafella; Teri Thomsen; Valerie Voon; Janis Miyasaki
Journal:  Ther Adv Neurol Disord       Date:  2013-05       Impact factor: 6.570

Review 5.  Dopamine Agonists and Impulse Control Disorders: A Complex Association.

Authors:  Marie Grall-Bronnec; Caroline Victorri-Vigneau; Yann Donnio; Juliette Leboucher; Morgane Rousselet; Elsa Thiabaud; Nicolas Zreika; Pascal Derkinderen; Gaëlle Challet-Bouju
Journal:  Drug Saf       Date:  2018-01       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.